| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.35B | $1.35B | $1.01B |
| YoY Revenue Growth % | +0.5% | +33.3% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $282.6M | $311.3M | $182.2M |
| Operating Margin % | 20.9% | 23.1% | 18.0% |
| Net Income (GAAP) | $333.5M | $179.0M | $95.6M |
| EBITDA (Normalized) | $303.2M | $333.4M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $379.1M | $282.5M | $104.2M |
| Capital Expenditures (CapEx) | $25.8M | $27.6M | — |
| Free Cash Flow (FCF) | $353.3M | $254.9M | $104.2M |
| FCF Margin % | 26.1% | 18.9% | 10.3% |
| Return on Invested Capital (ROIC %) | 15.6% | 18.1% | — |
| Cash & Short-Term Equivalents | $578.8M | $324.9M | — |
| Total Debt (Short + Long Term) | $649.0M | $571.7M | — |
| Total Stockholders' Equity | $1.37B | $1.11B | — |